OR WAIT null SECS
June 03, 2014
AMRI adds commercial-scale sterile injectable manufacturing capabilities with acquisition of Oso Biopharmaceuticals.
Aastrom acquires Sanofi's CTRM business unit for $6.5 million.
PharmaCell has finalized its purchase of the cell therapy production facility from TiGenix.
Provence Technologies? strengthens its expertise in therapeutic chemistry with acquisition of Synprosis.
May 29, 2014
Bristol-Myers Squibb announced collaborations with CytomX on probodies and with Incyte in an immunotherapy clinical trial.
Actavis develops a solid dosage manufacturing and packing facility at its Manati site in Puerto Rico.
May 27, 2014
GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.
May 23, 2014
GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.
May 22, 2014
Merck KGaA fill-finish expansion in Italy will be completed in 2017.
Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.